Renascience Inc.
Research Renascience Inc. (4889.T) on Bullrun: market cap JPY 14.29B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4889.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryMedical Devices
- CurrencyJPY
- Market capJPY 14.29B
- Financial periodFY2026
- RevenueJPY 68.55M
- Revenue growth-48.3%
- Net income-JPY 301.28M
- Free cash flow-JPY 291.31M
- Gross margin93.7%
Valuation Snapshot
latest market cap is JPY 14.29B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 68.55M | -JPY 301.28M | -JPY 291.31M | 93.7% | -23.39 | JPY 3.40B | n/a | JPY 3.32B |
| FY2025 | JPY 132.69M | JPY 113.43M | -JPY 177.14M | 97.2% | 8.92 | JPY 1.80B | JPY 0 | JPY 1.72B |
| FY2024 | JPY 194.17M | -JPY 258.34M | -JPY 232.10M | 85.3% | -20.32 | JPY 2.03B | JPY 356.10M | JPY 1.61B |
| FY2023 | JPY 100.55M | -JPY 335.80M | -JPY 286.87M | 99.8% | -26.42 | JPY 2.21B | JPY 309.60M | JPY 1.87B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 14.29B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 JPY.
About Renascience Inc.
Renascience Inc. develops and sells pharmaceuticals, medical devices, and artificial intelligence (AI)-powered programmed medical devices in Japan. The company is developing RS5614, a PAI-1 inhibitor product candidate for use in the treatment of chronic myeloid leukemia, malignant melanoma, non-small cell lung cancer, cutaneous angio-sarcoma, coronavirus lung injury, and interstitial lung disease associated with systemic scleroderma;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Renascience Inc.'s market cap?
Renascience Inc.'s market capitalization is JPY 14.29B.
What does Renascience Inc. do?
Renascience Inc. develops and sells pharmaceuticals, medical devices, and artificial intelligence (AI)-powered programmed medical devices in Japan.